CHKA and Hypoglycemia: Besides, after a single administration, DS-4108b was rapidly taken up and retained in the liver, with a half-life of approximately 4 weeks, which clearly reflected efficacy over a 12-week period for hepatic G6Pase activity, fasting hypoglycemia, and other parameters in cKI-Mut mice.